-
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy Diabetol. (IF 8.2) Pub Date : 2023-09-29 Marja-Riitta Taskinen, Niina Matikainen, Elias Björnson, Sanni Söderlund, Jussi Inkeri, Antti Hakkarainen, Helka Parviainen, Carina Sihlbom, Annika Thorsell, Linda Andersson, Martin Adiels, Chris J. Packard, Jan Borén
-
Mechanisms of kidney fibrosis and routes towards therapy Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-28 Noriyuki Yamashita, Rafael Kramann
Kidney fibrosis is the final common pathway of virtually all chronic kidney diseases (CKDs) and is therefore considered to be a promising therapeutic target for these conditions. However, despite great progress in recent years, no targeted antifibrotic therapies for the kidney have been approved, likely because the complex mechanisms that initiate and drive fibrosis are not yet completely understood
-
Metastases to the thyroid gland: how does this affect cytohistological diagnoses? Lancet Diabetes Endocrinol. (IF 44.5) Pub Date : 2023-09-28 Esther Diana Rossi, Liron Pantanowitz
Abstract not available
-
Unveiling the telomere–p53–PGC ageing axis Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-29 Subhajit Dutta
Telomeres are nucleoprotein structures that comprise repetitive nucleotide sequences bound to specialized proteins at the ends (tails) of chromosomes. Often compared to the plastic tips on shoelaces, telomeres cap the ends of chromosomes to prevent them unravelling or tangling. When a cell divides, it loses base pairs from the ends of its telomeres so that, with ageing, the telomeres become shorter;
-
Obesity is transferable through the gut microbiota Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-28 Béatrice S.-Y. Choi, Sune K. Yang-Jensen
Since the discovery in the 1600s of microscopic organisms, scientists have investigated the relationship between our health and the microbes that surround and inhabit us. Nowadays, we acknowledge that some microbes are inherently pathogenic, but also that others live mutualistically on and within our bodies and contribute to maintaining our well-being. Yet, one prominent challenge remains: to convincingly
-
DNA Methylation at ABCG1 and Long-Term Changes in Adiposity and Fat Distribution in Response to Dietary Interventions: The POUNDS Lost Trial Diabetes Care (IF 16.2) Pub Date : 2023-09-29 Xiang Li, Xiaojian Shao, Minghao Kou, Xuan Wang, Hao Ma, Elin Grundberg, Lydia A. Bazzano, Steven R. Smith, George A. Bray, Frank M. Sacks, Lu Qi
OBJECTIVE To examine whether participants with different levels of diabetes-related DNA methylation at ABCG1 might respond differently to dietary weight-loss interventions with long-term changes in adiposity and body fat distribution. RESEARCH DESIGN AND METHODS The current study included overweight/obese participants from the POUNDS Lost trial. Blood levels of regional DNA methylation at ABCG1 were
-
The Effectiveness of Shared Decision Making for Diabetes Prevention: 24- and 36-Month Results From the Prediabetes Informed Decision and Education (PRIDE) Trial Diabetes Care (IF 16.2) Pub Date : 2023-09-29 O. Kenrik Duru, Carol M. Mangione, Norman Turk, Janet Chon, Jeffery Fu, Grace Cheng, Felicia Cheng, Amanda Moss, Dominick Frosch, Kia Skrine Jeffers, Yelba Castellon-Lopez, Chi-Hong Tseng, Richard Maranon, Keith C. Norris, Tannaz Moin
OBJECTIVE We conducted a cluster-randomized, shared decision-making (SDM) trial offering lifestyle change, metformin, or both options, to adults at risk for diabetes in a primary care network (n = 20 practices). RESEARCH DESIGN AND METHODS We used propensity score matching to identify control patients and used electronic health record data to compare weight loss at 24 and 36 months of follow-up and
-
Alka Kanaya: representation in epidemiology Lancet Diabetes Endocrinol. (IF 44.5) Pub Date : 2023-09-26 Talha Burki
Abstract not available
-
What's in a decade? Lancet Diabetes Endocrinol. (IF 44.5) Pub Date : 2023-09-26
Abstract not available
-
Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes Diabetol. (IF 8.2) Pub Date : 2023-09-26 Tomoya Mita, Naoto Katakami, Yosuke Okada, Hidenori Yoshii, Takeshi Osonoi, Keiko Nishida, Toshihiko Shiraiwa, Akira Kurozumi, Naohiro Taya, Satomi Wakasugi, Fumiya Sato, Ryota Ishii, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada
-
Epigenome-Wide Meta-Analysis Reveals Associations Between Dietary Glycemic Index and Glycemic Load and DNA Methylation in Children and Adolescents of Different Body Sizes Diabetes Care (IF 16.2) Pub Date : 2023-09-27 Raffael Ott, Robert Stein, Helena H. Hauta–alus, Justiina Ronkainen, Sílvia Fernández–Barrés, Ulrike Spielau, Holger Kirsten, Tanja Poulain, Phillip E. Melton, Leanne K. Küpers, Hatim Azaryah, Marco Colombo, Kathrin Landgraf, Elmar W. Tobi, Therese O’Sullivan, Rae-Chi Huang, Cristina Campoy, Christiane Winkler, Jesus Vioque, Martine Vrijheid, Wieland Kiess, Antje Körner, Sylvain Sebert, Marjo-Riitta
OBJECTIVE Dietary glycemic index (GI) and glycemic load (GL) are associated with cardiometabolic health in children and adolescents, with potential distinct effects in people with increased BMI. DNA methylation (DNAm) may mediate these effects. Thus, we conducted meta-analyses of epigenome-wide association studies (EWAS) between dietary GI and GL and blood DNAm of children and adolescents. RESEARCH
-
Association of Unmet Social Needs With Metformin Use Among Patients With Type 2 Diabetes Diabetes Care (IF 16.2) Pub Date : 2023-09-27 Connor Drake, Jorge Morales Alfaro, Dan V. Blalock, Kristin Ito, Bryan C. Batch, Hayden B. Bosworth, Seth A. Berkowitz, Leah L. Zullig
OBJECTIVE To evaluate the relationship between social needs and metformin use among adults with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS In a prospective cohort study of adults with T2D (n = 722), we linked electronic health record (EHR) and Surescripts (Surescripts, LLC) prescription network data to abstract data on patient-reported social needs and to calculate metformin adherence based
-
Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission Diabetes Care (IF 16.2) Pub Date : 2023-09-27 Naveed Sattar, Shahrad Taheri, David P. Astling, Jessica Chadwick, Michael A. Hinterberg, Michael V. Holmes, Emma V. Troth, Paul Welsh, Hadeel Zaghloul, Odette Chagoury, Mike Lean, Roy Taylor, Steve Williams
OBJECTIVE To determine the extent to which changes in plasma proteins, previously predictive of cardiometabolic outcomes, predict changes in two diabetes remission trials. RESEARCH DESIGN AND METHODS We applied SomaSignal predictive tests (each derived from ∼5,000 plasma protein measurements using aptamer-based proteomics assay) to baseline and 1-year samples of trial intervention (Diabetes Remission
-
IL-6 trans-signaling is increased in diabetes, impacted by glucolipotoxicity and associated with liver stiffness and fibrosis in fatty liver disease Diabetes (IF 7.7) Pub Date : 2023-09-27 Aysim Gunes, Clémence Schmitt, Laurent Bilodeau, Catherine Huet, Assia Belblidia, Cindy Baldwin, Jeanne-Marie Giard, Laurent Biertho, Annie Lafortune, Christian Yves Couture, Angela Cheung, Bich N Nguyen, Eithan Galun, Chantal Bémeur, Marc Bilodeau, Mathieu Laplante, An Tang, May Faraj, Jennifer L. Estall
Many people living with diabetes also have non-alcoholic fatty liver disease (NAFLD). Interleukin-6 (IL-6) is involved in both diseases, interacting with both membrane-bound (classical) and circulating soluble receptors (trans-signaling). We investigated whether secretion of IL-6 trans-signaling co-receptors are altered in NAFLD by diabetes, and whether this might associate with the severity of fatty
-
Remission of prediabetes via lifestyle intervention Lancet Diabetes Endocrinol. (IF 44.5) Pub Date : 2023-09-25 Michael Bergman, Brenda Dorcely
Abstract not available
-
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS) Lancet Diabetes Endocrinol. (IF 44.5) Pub Date : 2023-09-25 Arvid Sandforth, Reiner Jumpertz von Schwartzenberg, Elsa Vazquez Arreola, Robert L Hanson, Gencer Sancar, Sarah Katzenstein, Karl Lange, Hubert Preißl, Simon I Dreher, Cora Weigert, Robert Wagner, Kostantinos Kantartzis, Jürgen Machann, Fritz Schick, Rainer Lehmann, Andreas Peter, Nikoletta Katsouli, Vasilis Ntziachristos, Corinna Dannecker, Louise Fritsche, Andreas L Birkenfeld
Background Remission of type 2 diabetes can occur as a result of weight loss and is characterised by liver fat and pancreas fat reduction and recovered insulin secretion. In this analysis, we aimed to investigate the mechanisms of weight loss- induced remission in people with prediabetes. Methods In this prespecified post-hoc analysis, weight loss-induced resolution of prediabetes in the randomised
-
N6-methyladenosine RNA modification in nonalcoholic fatty liver disease Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-25 Ping Luo, Shiqi Li, Wei Jing, Jiancheng Tu, Xinghua Long
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, influencing numerous regulatory axes and extrahepatic vital organs. The molecular mechanisms that lead to the progression of NAFLD remain unclear and knowledge on the pathways causing hepatocellular damage followed by lipid accumulation is limited. Recently, a number of studies have shown that mRNA N6-methyladenosine
-
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-25 Ibrahim AlZaim, Laura P.M.H de Rooij, Bilal N. Sheikh, Emma Börgeson, Joanna Kalucka
-
GWAS gives insights into glucose regulation Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-25 Claire Greenhill
Fasting levels of glucose and susceptibility to type 2 diabetes mellitus (T2DM) are known to have a large genetic component. Genome-wide association studies (GWASs) have identified hundreds of loci associated with these traits. However, glucose homeostasis is highly complex, so there are likely to be many more loci that influence how blood levels of glucose are regulated. A study has now taken the
-
Sex differences in cardiometabolic health Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-25 Ghulam Mehdi Dar
Women and men have different risk profiles for certain health conditions. For instance, differences in body composition between men and women are thought to partially underlie the different cardiometabolic risk profiles of men and women. Although men and women have similar levels of risk of obesity, their distribution of body adipose tissue differs. Men tend to carry excess weight as visceral adipose
-
Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National Registry Diabetes Care (IF 16.2) Pub Date : 2023-09-25 Maria Stepanova, Ameeta Kumar, Pamela Brandt, Nagashree Gundurao, Kenneth Cusi, Saleh Al Qahtani, Zobair M. Younossi
OBJECTIVE Type 2 diabetes (T2D) is a major driver of chronic diseases around the globe. The aim was to assess the impact of T2D on the outcomes of solid organ transplantations. RESEARCH DESIGN AND METHODS We used the Scientific Registry of Transplant Recipients from 2006 to 2021 to collect data for all patients age ≥18 years who received a lung, heart, liver, or kidney transplant in the U.S. RESULTS
-
Ethnic Differences in the Association Between Age at Natural Menopause and Risk of Type 2 Diabetes Among Postmenopausal Women: A Pooled Analysis of Individual Data From 13 Cohort Studies Diabetes Care (IF 16.2) Pub Date : 2023-09-25 Hsin-Fang Chung, Annette J. Dobson, Kunihiko Hayashi, Rebecca Hardy, Diana Kuh, Debra J. Anderson, Yvonne T. van der Schouw, Darren C. Greenwood, Janet E. Cade, Panayotes Demakakos, Eric J. Brunner, Sophie V. Eastwood, Sven Sandin, Elisabete Weiderpass, Gita D. Mishra
OBJECTIVE To investigate associations between age at natural menopause, particularly premature ovarian insufficiency (POI; natural menopause before age 40 years), and incident type 2 diabetes (T2D) and identify any variations by ethnicity. RESEARCH DESIGN AND METHODS We pooled individual-level data of 338,059 women from 13 cohort studies without T2D before menopause from six ethnic groups: White (n
-
Detection, mechanisms, and therapeutic implications of oncometabolites Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-20 Ying Cai, Zhibo Wang, Sifan Guo, Chunsheng Lin, Hong Yao, Qiang Yang, Yan Wang, Xiaodan Yu, Xiaowen He, Wanying Sun, Shi Qiu, Yu Guo, Songqi Tang, Yiqiang Xie, Aihua Zhang
Metabolic abnormalities are a hallmark of cancer cells and are essential to tumor progression. Oncometabolites have pleiotropic effects on cancer biology and affect a plethora of processes, from oncogenesis and metabolism to therapeutic resistance. Targeting oncometabolites, therefore, could offer promising therapeutic avenues against tumor growth and resistance to treatments. Recent advances in characterizing
-
National Prevalence of Diabetes and Barriers to Care Among U.S. Farmworkers and Association With Migrant Worker Status Diabetes Care (IF 16.2) Pub Date : 2023-09-22 Rose Mckeon Olson, Cody P. Nolan, Neha Limaye, Miriam Osei, Daniel Palazuelos
OBJECTIVE To quantify the prevalence of diabetes and barriers to care among U.S. migrant farmworkers (i.e. those who travel from their permanent residence for seasonal farmwork). RESEARCH DESIGN AND METHODS Age-adjusted prevalence of self-reported diabetes and barriers to care were calculated among adult U.S. farmworkers from 2008 to 2017 National Agricultural Workers Surveys. RESULTS Among 16,913
-
Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank Diabetol. (IF 8.2) Pub Date : 2023-09-20 Caiwei Tian, Charlyne Bürki, Kenneth E. Westerman, Chirag J. Patel
-
The challenges of identifying and studying type 1 diabetes in adults Diabetol. (IF 8.2) Pub Date : 2023-09-20 Nicholas J. Thomas, Angus G. Jones
-
Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy Diabetol. (IF 8.2) Pub Date : 2023-09-20 Xiaoli Hu, Christian Selmer Buhl, Marie Balle Sjogaard, Karoline Schousboe, Hatice Isik Mizrak, Huda Kufaishi, Troels Staehelin Jensen, Christian Stevns Hansen, Knud Bonnet Yderstræde, Ming-Dong Zhang, Patrik Ernfors, Jens Randel Nyengaard, Pall Karlsson
-
Alignment Between 24-h Light-Dark and Activity-Rest Rhythms Is Associated With Diabetes and Glucose Metabolism in a Nationally Representative Sample of American Adults Diabetes Care (IF 16.2) Pub Date : 2023-09-21 Qian Xiao, John Durbin, Cici Bauer, Chris Ho Ching Yeung, Mariana G. Figueiro
OBJECTIVE The alignment between environmental stimuli (e.g., dark, light) and behavior cycles (e.g., rest, activity) is an essential feature of the circadian timing system, a key contributor to metabolic health. However, no previous studies have investigated light-activity alignment in relation to glycemic control in human populations. RESEARCH DESIGN AND METHODS The analysis included ∼7,000 adults
-
Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study Diabetol. (IF 8.2) Pub Date : 2023-09-19 David M. Wright, Usha Chakravarthy, Radha Das, Katie W. Graham, Timos T. Naskas, Jennifer Perais, Frank Kee, Tunde Peto, Ruth E. Hogg
-
Effect of Postmenopausal Hormone Therapy on Glucose Regulation in Women With Type 1 or Type 2 Diabetes: A Systematic Review and Meta-analysis Diabetes Care (IF 16.2) Pub Date : 2023-09-20 Esther M. Speksnijder, Gaby V. ten Noever de Brauw, Arjan Malekzadeh, Peter H. Bisschop, Dirk Jan Stenvers, Sarah E. Siegelaar
BACKGROUND Blood glucose regulation in women with diabetes may change during and after menopause, which could be attributed, in part, to decreased estrogen levels. PURPOSE To determine the effect of postmenopausal hormone therapy (HT) on HbA1c, fasting glucose, postprandial glucose, and use of glucose-lowering drugs in women with type 1 and women with type 2 diabetes. DATA SOURCES We conducted a systematic
-
Artificial Intelligence and Diabetic Retinopathy: AI Framework, Prospective Studies, Head-to-head Validation, and Cost-effectiveness Diabetes Care (IF 16.2) Pub Date : 2023-09-20 Anand E. Rajesh, Oliver Q. Davidson, Cecilia S. Lee, Aaron Y. Lee
Current guidelines recommend that individuals with diabetes receive yearly eye exams for detection of referable diabetic retinopathy (DR), one of the leading causes of new-onset blindness. For addressing the immense screening burden, artificial intelligence (AI) algorithms have been developed to autonomously screen for DR from fundus photography without human input. Over the last 10 years, many AI
-
Exercised breastmilk: a kick-start to prevent childhood obesity? Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-19 Trine Moholdt, Kristin I. Stanford
Exercise has systemic health benefits through effects on multiple tissues, with intertissue communication. Recent studies indicate that exercise may improve breastmilk composition and thereby reduce the intergenerational transmission of obesity. Even if breastmilk is considered optimal infant nutrition, there is evidence for variations in its composition between mothers who are normal weight, those
-
Computed Tomography Versus Invasive Coronary Angiography in Patients With Diabetes and Suspected Coronary Artery Disease Diabetes Care (IF 16.2) Pub Date : 2023-09-19 Theodora Benedek, Viktoria Wieske, Bálint Szilveszter, Klaus F. Kofoed, Patrick Donnelly, José Rodriguez-Palomares, Andrejs Erglis, Josef Veselka, Gintarė Šakalytė, Nada Čemerlić Ađić, Matthias Gutberlet, Ignacio Diez, Gershan Davis, Elke Zimmermann, Cezary Kępka, Radosav Vidakovic, Marco Francone, Małgorzata Ilnicka-Suckiel, Fabian Plank, Juhani Knuuti, Rita Faria, Stephen Schröder, Colin Berry, Luca
OBJECTIVE To compare cardiac computed tomography (CT) with invasive coronary angiography (ICA) as the initial strategy in patients with diabetes and stable chest pain. RESEARCH DESIGN AND METHODS This prespecified analysis of the multicenter DISCHARGE trial in 16 European countries was performed in patients with stable chest pain and intermediate pretest probability of coronary artery disease. The
-
Phenotypic characterization of congenital hyperinsulinism due to novel activating glucokinase mutations Diabetes (IF 7.7) Pub Date : 2023-09-19 Changhong Li, Christine A. Juliana, Yue Yuan, Ming Li, Ming Lu, Pan Chen, Kara E. Boodhansingh, Nicolai M. Doliba, Tricia R. Bhatti, N. Scott Adzick, Charles A. Stanley, Diva D. De León
The importance of glucokinase (GK) in the regulation of insulin secretion has been highlighted by the phenotypes of individuals with activating and inactivating mutations in the glucokinase gene (GCK). Here we report 10 cases of congenital hyperinsulinism (HI) caused by eight unique activating mutations of GCK. Six are novel and near previously identified activating mutations sites. The first recognized
-
A maternal Western-style diet impairs skeletal muscle lipid metabolism in adolescent Japanese macaques Diabetes (IF 7.7) Pub Date : 2023-09-19 Keenan T. Greyslak, Byron Hetrick, Bryan C. Bergman, Tyler A. Dean, Stephanie R. Wesolowski, Maureen Gannon, Simon Schenk, Elinor L. Sullivan, Kjersti M. Aagaard, Paul Kievit, Adam J. Chicco, Jacob E. Friedman, Carrie E. McCurdy
Maternal (m) consumption of a Western-style diet (WD) during pregnancy alters fatty-acid metabolism and reduces insulin sensitivity in fetal skeletal muscle. The long-term impact of these fetal adaptations and the pathways underlying disordered lipid metabolism are incompletely understood. Therefore, we tested whether a mWD chronically fed to lean, insulin sensitive adult Japanese macaques throughout
-
MAD2-dependent insulin receptor endocytosis regulates metabolic homeostasis Diabetes (IF 7.7) Pub Date : 2023-09-19 Junhee Park, Catherine Hall, Brandon Hubbard, Traci LaMoia, Rafael Gaspar, Ali Nasiri, Fang Li, Hanrui Zhang, Jiyeon Kim, Rebecca A. Haeusler, Domenico Accili, Gerald I. Shulman, Hongtao Yu, Eunhee Choi1
Insulin activates insulin receptor (IR) signaling and subsequently triggers IR endocytosis to attenuate signaling. Cell division regulators MAD2, BUBR1, and p31comet promote IR endocytosis upon insulin stimulation. Here, we show that genetic ablation of the IR–MAD2 interaction in mice delays IR endocytosis, increases IR levels, and prolongs insulin action at the cell surface. This in turn causes a
-
Structural and metabolic retinal changes associated with mild cognitive impairment in type 2 diabetes Diabetes (IF 7.7) Pub Date : 2023-09-19 Frederik N Pedersen, Lonny Stokholm, Noemi Lois, Dawei Yang, Carol Y Cheung, Geert Jan Biessels, Lieza Exalto, Rafael Simó, Tunde Peto, Frans Pouwer, Jakob Grauslund
Type 2 diabetes is associated with cognitive impairment and a twofold increased risk of dementia compared to age-matched individuals without diabetes. Given that the eye and the brain share similar embryologic origin and anatomical features the retina offers a unique “window” to the brain. In this study we wanted to determine whether there was a difference in retinal imaging-based neuronal and vascular
-
Association of both short-term and long-term glycemic variability with the development of microalbuminuria in the ACCORD trial Diabetes (IF 7.7) Pub Date : 2023-09-19 Tomoki Okuno, Arin Vansomphone, Elyse Zhang, Hua Zhou, Juraj Koska, Peter Reaven, Jin J. Zhou
Both long- and short-term glycemic variability have been associated with incident diabetes complications. We evaluated their relative and potential additive effects on incident renal complications in the Action to Control Cardiovascular Risk in Diabetes trial. A marker of shortterm glycemic variability 1,5-anhydroglucitol (1,5-AG) was measured in 4,000 random 12-months post-randomization plasma samples
-
Road map for personalized exercise medicine in T2DM Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-18 Christian Brinkmann
The number of patients with type 2 diabetes mellitus (T2DM) is rising at an alarming rate. Regular physical activity and exercise are cornerstones in the therapy of T2DM. While a one-size-fits-all approach fails to account for many between-subject differences, the use of personalized exercise medicine has the potential of optimizing health outcomes. Here, a road map for personalized exercise therapy
-
A seasonal switch hypothesis for the neuroendocrine control of aggression Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-17 Gregory E. Demas, Kathleen M. Munley, Aaron M. Jasnow
Aggression is a well-studied social behavior that is universally exhibited by animals across a wide range of contexts. Prevailing knowledge suggests gonadal steroids primarily mediate aggression; however, this is based mainly on studies of male–male aggression in laboratory rodents. When males and females of other species, including humans, are examined, a positive relationship between gonadal steroids
-
Blocking hemopexin with specific antibodies: a new strategy for treating diabetic retinopathy Diabetes (IF 7.7) Pub Date : 2023-09-18 Patricia Bogdanov, Anna Duarri, David Sabater, Anna Salas, Helena Isla-Magrané, Hugo Ramos, Jordi Huerta, Marta Valeri, José García-Arumí, Rafael Simó, Cristina Hernández
Hemopexin (HPX) is overexpressed in the retina of diabetic patients, and induces the breakdown of the blood-retinal barrier (BRB) in vitro. The present study was aimed at evaluating whether HPX blockade by specific antibodies (aHPX) could avoid vascular leakage in vivo and microvascular angiogenesis in vitro and ex vivo. For this purpose, the effect of intravitreal injections (IVT) of aHPX on vascular
-
Protease-Activated Receptor 1 Mediated Damage of Podocytes in Diabetic Nephropathy Diabetes (IF 7.7) Pub Date : 2023-09-18 Ruslan Bohovyk, Sherif Khedr, Vladislav Levchenko, Mariia Stefanenko, Marharyta Semenikhina, Olha Kravtsova, Elena Isaeva, Aron M. Geurts, Christine A. Klemens, Oleg Palygin, Alexander Staruschenko
There is clinical evidence that increased urinary serine proteases are associated with the disease severity in the setting of diabetic nephropathy (DN). Elevation of serine proteases may mediate [Ca2+]i dynamics in podocytes through the protease-activated receptors (PARs) pathway, including associated activation of non-specific cation channels. Cultured human podocytes and freshly isolated glomeruli
-
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial Diabetol. (IF 8.2) Pub Date : 2023-09-16 Sara J. Cromer, Tanayott Thaweethai, Deborah J. Wexler
-
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis Diabetol. (IF 8.2) Pub Date : 2023-09-15 Kavaljit H. Chhabra, Siresha Bathina, Tumininu S. Faniyan, Dennis J. Samuel, Muhammad Ummear Raza, Leticia Maria de Souza Cordeiro, Gonzalo Viana Di Prisco, Brady K. Atwood, Jorge Robles, Lauren Bainbridge, Autumn Davis
-
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells Diabetol. (IF 8.2) Pub Date : 2023-09-15 Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, Roberta Cappellari, Angelo Avogaro, Gian Paolo Fadini
-
Quantifying beta cell function in the preclinical stages of type 1 diabetes Diabetol. (IF 8.2) Pub Date : 2023-09-15 Alfonso Galderisi, Alice L. J. Carr, Mariangela Martino, Peter Taylor, Peter Senior, Colin Dayan
-
Pituitary crosstalk with bone, adipose tissue and brain Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-15 Mone Zaidi, Tony Yuen, Se-Min Kim
-
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial Diabetes Care (IF 16.2) Pub Date : 2023-09-15 Dennis I. Narcisse, Hwasoon Kim, Lisa M. Wruck, Amanda L. Stebbins, Daniel Muñoz, Sunil Kripalani, Mark B. Effron, Kamal Gupta, R. David Anderson, Sandeep K. Jain, Saket Girotra, Jeff Whittle, Catherine P. Benziger, Peter Farrehi, Li Zhou, Tamar S. Polonsky, Faraz S. Ahmad, Matthew T. Roe, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez, W. Schuyler Jones
OBJECTIVE Patients with diabetes mellitus (DM) and concomitant atherosclerotic cardiovascular disease (ASCVD) must be on the most effective dose of aspirin to mitigate risk of future adverse cardiovascular events. RESEARCH DESIGN AND METHODS ADAPTABLE, an open-label, pragmatic study, randomized patients with stable, chronic ASCVD to 81 mg or 325 mg of daily aspirin. The effects of aspirin dosing was
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis Diabetes Care (IF 16.2) Pub Date : 2023-09-15 Ana Devesa, Valentin Fuster, Ravi Vazirani, Inés García-Lunar, Belén Oliva, Samuel España, Andrea Moreno-Arciniegas, Javier Sanz, Cristina Perez-Herreras, Héctor Bueno, Enrique Lara-Pezzi, Ana García-Alvarez, Vicente Martínez de Vega, Leticia Fernández-Friera, Maria G. Trivieri, Antonio Fernández-Ortiz, Xavier Rossello, Javier Sanchez-Gonzalez, Borja Ibanez
OBJECTIVE Experimental evidence suggests that metabolic syndrome (MetS) is associated with changes in cardiac metabolism. Whether this association occurs in humans is unknown. RESEARCH DESIGN AND METHODS 821 asymptomatic individuals from the Progression of Early Subclinical Atherosclerosis (PESA) study (50.6 [46.9–53.6] years, 83.7% male) underwent two whole-body 18F-fluorodeoxyglucose positron emission
-
Brain–body communication in metabolic control Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-14 Alessandro Furlan, Paul Petrus
A thorough understanding of the mechanisms controlling energy homeostasis is needed to prevent and treat metabolic morbidities. While the contribution of organs such as the liver, muscle, adipose tissue, and pancreas to the regulation of energy has received wide attention, less is known about the interplay with the nervous system. Here, we highlight the role of the nervous systems in regulating metabolism
-
The dangerous trend of levothyroxine medicalization Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-13 Jan Calissendorff
Thyroid hormone replacement is paramount in overt hypothyroidism; recently, however, thyroid hormone substitution is increasingly prescribed to patients with normal thyroid hormone levels. This forum article discusses the complex causes and the possible negative effects of overusing thyroid hormone replacement drugs.
-
Advisory Board and Contents Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-12
Abstract not available
-
Subscription and Copyright Information Trends Endocrin. Met. (IF 10.9) Pub Date : 2023-09-12
Abstract not available
-
Length of light exposure alters energy metabolism in mice Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-13 Claire Greenhill
Circadian rhythms, which are influenced by the light and dark that an organism is exposed to, have important effects on physiology. Traditionally, laboratory studies of circadian rhythms have used a 12-h light and 12-h dark experimental set up (photoperiod). However, apart from regions close to the Equator, the photoperiod varies throughout the year. A study in Cell Metabolism has now investigated
-
Long-term effects of untreated leptin deficiency Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-11 Claire Greenhill
Deficiencies in leptin signalling cause severe early-onset obesity due to hyperphagia. A new study has investigated the long-term clinical outcomes for children with leptin signalling deficiency who do not receive treatment for the condition.
-
Microbial metabolism linked to insulin resistance Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-11 Shimona Starling
A new study in Nature has used a comprehensive multi-omics strategy in humans to uncover mechanisms by which carbohydrate metabolism by the gut microbiota contributes to insulin resistance.
-
Control of adipose tissue cellularity by the terminal complement cascade Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-11 Ilja L. Kruglikov, Philipp E. Scherer
-
Inflammation-induced adrenal dysfunction Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-11 Vasileios Chortis, David T. Breault
Acute inflammation triggers activation of the hypothalamic–pituitary–adrenal axis, but whether it could also impede the adrenocortical response to adrenocorticotropic hormone remains controversial. A new study using preclinical models of acute inflammation demonstrates dysregulation of energy metabolism in adrenocortical cells, resulting in oxidative stress that induces disruption of steroidogenesis
-
Non-invasive daily profiles of tissue adrenal steroids Nat. Rev. Endocrinol. (IF 40.5) Pub Date : 2023-09-11 Fidéline Bonnet-Serrano, Jérôme Bertherat
In a new study, an ambulatory microdialysis system combined with ultrasensitive liquid chromatography-tandem mass spectrometry enabled the building of a 24-h high-resolution profile of adrenal steroids in the tissue by sampling interstitial fluid in 214 healthy volunteers. Daily and ultradian variations of eight free steroids, including cortisol and aldosterone, have been demonstrated, which opens
-
Family Typology for Adults With Type 2 Diabetes: Longitudinal Stability and Validity for Diabetes Management and Well-Being Diabetes Care (IF 16.2) Pub Date : 2023-09-14 Lindsay S. Mayberry, Shilin Zhao, McKenzie K. Roddy, Andrew J. Spieker, Cynthia A. Berg, Lyndsay A. Nelson, Robert A. Greevy
OBJECTIVE We validated longitudinally a typology of diabetes-specific family functioning (named Collaborative and Helpful, Satisfied with Low Involvement, Want More Involvement, and Critically Involved) in adults with type 2 diabetes. RESEARCH DESIGN AND METHODS We conducted k-means cluster analyses with nine dimensions to determine if the typology replicated in a diverse sample and if type assignment